<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
	<HEAD>
		<META HTTP-EQUIV="Content-Type" CONTENT="text/html;CHARSET=iso-8859-1">
	</HEAD>
	<TITLE>Translation File for NYC DOH Tuberculosis Testing & Treatment Guidline v. 0.0 2003-03-7</TITLE>
<BODY>
	<P ALIGN='center'><b>Logic File for NYC DOH Tuberculosis Testing & Treatment Guidline v. 0.0 2003-03-7</b></P>
	<TABLE border='1'>
		<tr><td width="5%"><b>#</b></td><td width="%15"><b>Variable Name</b></td><td width="15%"><b>Relevance</b></td><td width='40%'><b>Question</b></td><td width='20%'><b>Answers</b></td></tr>
		<tr><td>1</td><td>overall_intro_1</td><td>1</td><td>This is an implementation of the <b>New York City Department of Health</b> guideline for testing and treatment of <b>Latent Tuberculosis Infection (LTBI)</b>. <br>The guideline is composed of five basic steps:  <br>1)   decide who should be tested.  <br>2)  decide if the tuberculin skin test (TST) is positive.  <br>3)  evaluate for the presence of active disease.  <br>4)  select a treatment regimen for latent infection. <br>5)  make any adjustments for HIV-positive patients.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>2</td><td>overall_intro_2</td><td>1</td><td>It operationalizes the guideline to help you decide whether a tuberculin skin test is necessary and, if one has been done, to decide how to interpret the test and handle positive results.<br><br>Tuberculin skin testing should only take place when a plan has been developed for persons to complete a course of treatment if found to have latent TB infection.  <br><b>Remember, a decision to test is a commitment to treat!</b></td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>3</td><td>age</td><td>1</td><td>What is your patient's age?</td><td><font color='blue'><b>[Data type = </b>number]</font></td></tr>
		<tr><td>4</td><td>Intro_1</td><td>1</td><td><b>Step 1: Know Which Persons Are at High Risk for TB Infection or Disease and Should Be Tested for Latent TB Infection</b><br><br> The following descriptions characterize persons who are at high risk for TB infection or disease because they may have been recently infected.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>5</td><td>TB_contacts</td><td>1</td><td>Has your patient had close contact with someone who has active TB?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>6</td><td>previous_positive</td><td>1</td><td>Has your patient had a TST that has converted to positive (that is, a 10mm or more increase in induration) within the past 2 years?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>7</td><td>previous_TB_untreated</td><td>1</td><td>Does your patient have a history of TB which was untreated or inadequately treated?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>8</td><td>recent_immigrant</td><td>1</td><td>Has your patient immigrated within the past 5 years from areas with high rates of TB?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>9</td><td>exposure_settings</td><td>1</td><td>Does your patient live or work in an institutional setting where TB exposure may be likely (e.g., hospitals, prisons, homeless shelters, nursing homes)?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>10</td><td>intro_1b</td><td>1</td><td>The following descriptions characterize patients who are at increased risk for progressing to active TB disease.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>11</td><td>HIV</td><td>1</td><td>Is your patient infected with human immunodeficiency virus (HIV)?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>12</td><td>IVDA</td><td>1</td><td>Does your patient abuse injection drugs, particulary if HIV-positive?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>13</td><td>old_TB</td><td>1</td><td>Does your patient have evidence of old, healed TB lesions on a chest X-ray?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>14</td><td>associated_condition</td><td>1</td><td>Does your patient have a clinical condition that could lead to a stressed or incompetent immune system (e.g., silicosis, chronic renal failure, diabetes mellitus)?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>15</td><td>immune_suppression</td><td>1</td><td>Is your patient receiving prolonged corticosteroid or other immunosuppressive therapy?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>16</td><td>under_weight</td><td>1</td><td>Is your patient underweight (that is, 10% or more below ideal body weight)?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>17</td><td>weight</td><td>(under_weight == 3)</td><td>One method of determining the whether your patient is underweight is by using the body mass index.  Being 10% or more underweight corresponds to a BMI of 20 or less.<br>Enter your patient's weight (in pounds):</td><td><font color='blue'><b>[Data type = </b>number]</font></td></tr>
		<tr><td>18</td><td>height</td><td>(under_weight == 3)</td><td>Enter your patient's height (in inches):</td><td><font color='blue'><b>[Data type = </b>number]</font></td></tr>
		<tr><td>19</td><td>BMI</td><td>(under_weight == 3)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br> (weight * 0.45359) / ((height * 0.0254) * (height * 0.0254))</td><td>&nbsp;</td></tr>
		<tr><td>20</td><td>weight_recommendation</td><td>(under_weight == 3)</td><td>The BMI is `BMI` so your patient is `(BMI < 20)?"":"not"` more than 10% below ideal body weight. <br><br>Use the <i>PREVIOUS</i> button to return to the underweight question and record the answer.   </td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>21</td><td>exposed_child</td><td>(age < 5)</td><td>Is this child exposed to adults in high risk categories?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>22</td><td>exposure_window</td><td>(TB_contacts == 1)</td><td>Was the first exposure to active TB within the past 12 weeks?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>23</td><td>risk_list</td><td>1</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>list((TB_contacts == 1)?desc(TB_contacts):"",(previous_positive == 1)?desc(previous_positive):"", (recent_immigrant == 1)?desc(recent_immigrant):"", (exposure_settings == 1)?desc(exposure_settings):"", (age < 5)?"is a child under the age of 5 years":"", (HIV == 1)?desc(HIV):"", (IVDA == 1)?desc(IVDA):"", (old_TB == 1)?desc(old_TB):"", (under_weight == 1)?desc(under_weight):"", (associated_condition == 1)?desc(associated_condition):"", (immune_suppression == 1)?desc(immune_suppression):"")</td><td>&nbsp;</td></tr>
		<tr><td>24</td><td>high_risk</td><td>1</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>(TB_contacts  == 1) || (previous_positive == 1) || (recent_immigrant == 1) || (exposure_settings == 1) || (exposed_child == 1) || (HIV == 1) || (IVDA == 1) || (old_TB == 1) || (under_weight == 1) || (associated_condition == 1) || (immune_suppression == 1)</td><td>&nbsp;</td></tr>
		<tr><td>25</td><td>risk_report</td><td>1</td><td>`(high_risk == 1)?"Your patient is at <b>high risk</b> due to the following -- ". risk_list . "."  :"Overall, your patient is at <b>low risk</b>."`  </td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>26</td><td>recent_exposure_under_5</td><td>(high_risk == 1) && (exposure_window == 1) && (age < 5)</td><td>Since this child under 5 years old was exposed within the past 12 weeks, the TST may be falsely negative. Active TB should be ruled out with a medical exam and a chest X-ray and treatment should be started for presumed latent TB infection with or without a TST.  <br><br>If TST results remain negative after the window period, treatment should be discontinued.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>27</td><td>recent_exposure_HIV</td><td>(high_risk == 1) && (exposure_window == 1) && (HIV == 1)</td><td>Since this HIV-positive person was exposed within the past 12 weeks, the TST may be falsely negative.  Active TB should be ruled out with a medical exam and a chest X-ray and treatment should be started for presumed latent TB infection without regard for the results of a TST.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>28</td><td>test_done</td><td>1</td><td>Has a tuberculin skin test been done?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>29</td><td>patient_state_1</td><td>(high_risk == 1) && (test_done == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>1</td><td>&nbsp;</td></tr>
		<tr><td>30</td><td>patient_state_2</td><td>!(high_risk == 1) && (test_done == 1)</td><td>Routine tuberculin skin testing of persons at low risk for TB infection or disease is <b>not</b> recommended.  An individual not at high risk for developing TB disease who has been inadvertently tested should generally <b>not</b> be considered for treatment, <b>even if the TST test is positive</b>.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>31</td><td>patient_state_3</td><td>(high_risk == 1) && !(test_done ==1)</td><td>At this point you should suspend this guideline and test the patient.  Resume the guideline when the TST result is known.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>32</td><td>patient_state_4</td><td>!(high_risk == 1) && !(test_done == 1)</td><td>No testing or treatment is necessary unless the history or clinical situation change.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>33</td><td>Intro_2</td><td>(patient_state_1 == 1) || (patient_state_2 == 1)</td><td><b>Step 2:  Determine if the Tuberculin Skin Test is Positive</b></td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>34</td><td>Induration</td><td>(patient_state_1 == 1) || (patient_state_2 == 1)</td><td>If a tuberculin skin test has already been done (even if the patient was at low risk), please indicate the measurement of induration (mm).</td><td><font color='blue'><b>[Data type = </b>number]</font></td></tr>
		<tr><td>35</td><td>TST_positive_5mm</td><td>(patient_state_1 == 1) || (patient_state_2 == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>(Induration >= 5) && ((HIV == 1) || (TB_contacts == 1) || (old_TB == 1) || (immune_suppression == 1))</td><td>&nbsp;</td></tr>
		<tr><td>36</td><td>TST_positive_10mm</td><td>(patient_state_1 == 1) || (patient_state_2 == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>(Induration >= 10) && ((recent_immigrant == 1) || (IVDA == 1) || (exposure_settings == 1) || (associated_condition == 1) || (age < 5) || (exposed_child == 1) || under_weight == 1))</td><td>&nbsp;</td></tr>
		<tr><td>37</td><td>TST_positive_15mm</td><td>(patient_state_1 == 1) || (patient_state_2 == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>(Induration >= 15) && (high_risk != 1)</td><td>&nbsp;</td></tr>
		<tr><td>38</td><td>TST_positive</td><td>(patient_state_1 == 1) || (patient_state_2 == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>(TST_positive_5mm == 1) || (TST_positive_10mm == 1) || (TST_positive_15mm == 1)</td><td>&nbsp;</td></tr>
		<tr><td>39</td><td>TST_negative</td><td>(patient_state_1 == 1) || (patient_state_2 == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>(TST_positive != 1)</td><td>&nbsp;</td></tr>
		<tr><td>40</td><td>report_TST</td><td>1</td><td>`(TST_negative == 1)?"This is a <b>negative</b> result and, therefore, no treatment is necessary.":"This is a <b>positive</b> result so we will proceed to Step 3."`</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>41</td><td>Intro_3</td><td>(TST_positive == 1) || (recent_exposure_under_5 == 1) || (recent_exposure_HIV == 1)</td><td><b>Step 3:  Evaluate for Active TB Disease</b></td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>42</td><td>TST_positive_report</td><td>(TST_positive == 1) || (recent_exposure_under_5 == 1) || (recent_exposure_HIV == 1)</td><td>The guidelines recommend further evaluation for active TB disease with a medical examination and a chest X-ray due to the following:   `list((TST_positive ==1)?"this is a <b>positive</b> TST result.":"", ((age < 5) && (exposure_window == 1))?"this is a child under age 5 exposed within the past 12 weeks to active TB":"", ((HIV == 1) && (exposure_window == 1))?"this HIV-infected individual was exposed within the past 12 weeks to active TB":"") `.  </td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>43</td><td>TST_positive_under_5</td><td>(TST_positive == 1) && (age < 5)</td><td>Since your patient is younger than 5 years old and has a positive TST this must be reported to the Health Department.  Call (212) 788-4162.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>44</td><td>active_TB_suspected</td><td>(TST_positive == 1) || (recent_exposure_under_5 == 1) || (recent_exposure_HIV == 1)</td><td>Do you suspect or have you confirmed that your patient has active TB?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>45</td><td>report_active_TB</td><td>(active_TB_suspected == 1)</td><td>To report a case of suspected or confirmed TB disease to the Health Department, call (212) 788-4162.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>46</td><td>should_treat_LTBI</td><td>((TST_positive == 1) || (recent_exposure_under_5 == 1) || (recent_exposure_HIV == 1)) && !(active_TB_suspected == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>[(TST_positive == 1) || (recent_exposure_HIV == 1) || ((HIV == 1) && (previous_TB_untreated == 1)) || (recent_exposure_under_5 ==1)] && !(active_TB_suspected == 1)</td><td>&nbsp;</td></tr>
		<tr><td>47</td><td>report_LTBI</td><td>((TST_positive == 1) || (recent_exposure_under_5 == 1) || (recent_exposure_HIV == 1)) && !(active_TB_suspected == 1)</td><td>This qualifies as a case of latent tuberculosis infection.  We will now proceed to Step 4.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>48</td><td>Intro_4</td><td>(should_treat_LTBI == 1)</td><td><b>Step 4:  Give treatment for Latent TB Infection</b><br><br>The next series of questions will help determine the regimen that is best.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>49</td><td>pregnant</td><td>(should_treat_LTBI == 1)</td><td>Is your patient pregnant?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>50</td><td>postpartum</td><td>(should_treat_LTBI == 1)</td><td>Is your patient less than 3 months post-partum?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>51</td><td>liver_disease_history</td><td>(should_treat_LTBI == 1)</td><td>Has your patient had any liver disease in the past?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>52</td><td>chronic_hepatitis</td><td>(should_treat_LTBI == 1)</td><td>Does your patient have chronic hepatitis?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>53</td><td>alcohol_abuse</td><td>(should_treat_LTBI == 1)</td><td>Does your patient have a history of alcohol abuse?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>54</td><td>previous_TB_treatment</td><td>(should_treat_LTBI == 1)</td><td>Has your patient ever received TB treatment?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>55</td><td>tolerates_INH</td><td>(should_treat_LTBI == 1)</td><td>Can your patient take INH?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>56</td><td>tolerates_PZA</td><td>(should_treat_LTBI == 1)</td><td>Can your patient tolerate PZA?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>57</td><td>suspect_INH_resistance</td><td>(should_treat_LTBI == 1) && (TB_contacts == 1)</td><td>You reported that your patient had close contact with someone who has active TB.  Was this INH-resistant TB?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>58</td><td>suspect_MDRTB</td><td>(should_treat_LTBI == 1) && (TB_contacts == 1)</td><td>Was it multi-drug resistant TB?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>59</td><td>treat_MDRTB</td><td>(should_treat_LTBI == 1) && (suspect_MDRTB == 1)</td><td>Contacts of persons with multidrug-resistant TB (MDRTB) are unlikely to benefit from treatment with isoniazid or rifampin.  Therefore a regimen containing other drugs active against M. tuberculosis should be considered.  When possible, selection of drugs should be guided by in vitro susceptibility test results on an isolate obtained from the person to whom the patient was exposed.  Immunocompetent contacts may be observed without treatment or treated for at least 6 months.  HIV-infected persons should be treated for 12 months.  All persons with suspected MDRTB infection should be followed for at least 2 years, irrespective of treatment.  Expert consultation should be sought for the treatment of persons exposed to persons with MDRTB.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>60</td><td>using_antiretrovirals</td><td>(should_treat_LTBI == 1) && (HIV == 1) && !(tolerates_INH == 1)</td><td>Is your patient being treated with protease inhibitors and non-nucleoside reverse transcriptase inhibitors?</td><td>[0] no<br />[1] yes<br />[3] Unknown<br />&nbsp;</td></tr>
		<tr><td>61</td><td>intro_treat</td><td>(should_treat_LTBI == 1)</td><td>What follows are the recommended treatment for your patient: (please click the "next" button)</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>62</td><td>pregnant_TST_positive</td><td>(should_treat_LTBI == 1) && (pregnant == 1)</td><td>Although the need for treatment of active TB during pregnancy is unquestioned, the treatment of LTBI in pregnant women is more controversial because the possible risk of isoniazid hepatotoxicity must be weighed against the risk of developing active TB.  In general, treatment of LTBI should be delayed until after delivery.  However, for women who are HIV-positive or who have been infected recently, initiation of thereapy should not be delayed on the basis of pregnancy alone, even during the first trimester.<br><br>The preferred regimen for treatment of LTB in pregnant women is INH (daily or twice weekly).  Extensive use of INH during pregancy has indicated that the drug is not teratogenic, even when given during the first 4 months of pregnancy.  Pregnant women taking INH should receive vitamin B6.  In general, pyrazinamide should not be used for the treatment of LTBI in pregnant women.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>63</td><td>treat_INH_9months</td><td>(should_treat_LTBI == 1) && !(old_TB == 1) && !(suspect_MDRTB == 1) && (tolerates_INH == 1)</td><td>Since your patient can tolerate INH:<br>Drug:  isoniazid (INH)<br>Duration: 9 months<br>Daily dosage:  5 mg/kg (300 mg) -- Criteria for Completion:  270 doses within 12 months<br>Twice Weekly dosage: 15 mg/kg (900 mg) -- Criteria for Completion: 76 doses within 12 months<br></td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>64</td><td>treat_INH_6months</td><td>(should_treat_LTBI == 1) && !(old_TB == 1) && !(suspect_MDRTB == 1) && (tolerates_INH == 1 ) && !(HIV == 1)</td><td>Since your patient is not HIV-positive an alternative regimen is:<br>Drug:  isoniazid (INH)<br>Duration: 6 months<br>Daily dosage:  5 mg/kg (300 mg) -- Criteria for Completion:  180 doses within 9 months<br>Twice Weekly dosage: 15 mg/kg (900 mg) -- Criteria for Completion: 52 doses within 9 months<br></td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>65</td><td>treat_rifampin_PZA</td><td>(should_treat_LTBI == 1) && !(old_TB == 1) && !(suspect_MDRTB == 1) && (!(tolerates_INH == 1 ) || (suspect_INH_resistance == 1)) && !(pregnant == 1) && (tolerates_PZA == 1)) && !(using_antiretrovirals == 1) </td><td>When INH-resistance is suspected or a patient cannot tolerate INH, a recommended regimen is:<br>Drug:  rifampin (RIF) plus pyrazinamide (PZA)<br>Duration: 2 months<br>Daily dosage:  RIF 10 mg/kg (600 mg max), PZA 15-20 mg/kg (2.0 g max) -- Criteria for Completion: 60 doses within 3 months<br>Twice Weekly dosage:  RIF 10 mg/kg (600 mg max), PZA 15-20 mg/kg (2.0 g max) -- Criteria for Completion:  16 doses within 3 months</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>66</td><td>treat_rifampin</td><td>(should_treat_LTBI == 1) && !(old_TB == 1) && !(suspect_MDRTB == 1) && !(tolerates_INH == 1) && ((pregnant == 1) || !(tolerates_PZA == 1))</td><td>When cannot tolerate or safely take either INH or PZA, a recommended regimen is:<br>Drug:  rifampin (RIF)<br>Duration:  4 months<br>Daily dosage:  10 mg/kg (600 mg max) -- Criteria for Completion:  120 doses within 6 months</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>67</td><td>treat_old_TB_no_previous_treatment_no_HIV</td><td>(should_treat_LTBI == 1) && (old_TB == 1) && !(suspect_MDRTB == 1) && !(HIV == 1) && !(previous_TB_treatment == 1)</td><td>Since your patient has evidence of old, healed TB without a history of prior TB treatment, the appropriate treatment is isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months followed by isoniazid and rifamipn for 2 months.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>68</td><td>treat_old_TB_previous_treatment_HIV</td><td>(should_treat_LTBI == 1) && (old_TB == 1) && !(suspect_MDRTB == 1) && [(HIV == 1) || (previous_TB_treatment == 1)]</td><td>Your patient has evidence of old, healed TB, `(HIV == 1)?"is HIV-positive,":""` `(previous_TB_treatment == 1)?" and has a history of prior treatment with anti-TB medications,":""` so should receive isoniazid, rifampin, pyrazinamide, and ethambutol for 4 months.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>69</td><td>intro_5</td><td>(should_treat_LTBI == 1) && (HIV == 1) && !(tolerates_INH == 1) && (using_antiretrovirals == 1)</td><td><b>Step 5:  Adjust Treatment in HIV-positive Patients on Antiretroviral Agents</b></td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>70</td><td>rifabutin_for_rifampin</td><td>(should_treat_LTBI == 1) && (HIV == 1) && !(tolerates_INH == 1) && (using_antiretrovirals == 1)</td><td>Since your HIV-infected patient is taking antiretrovirals, you should substitute rifabutin for rifampin.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>71</td><td>intro_monitoring</td><td>(should_treat_LTBI == 1)</td><td>All patients receiving treatment for latent TB infection should be monitored clinically.  This involves education of patients about the signs and symptoms of adverse drug reactions and the need for prompt cessation of treatment and clinical evaluation should symptoms occur.  Blood tests are necessary for some patients.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>72</td><td>baseline_indications</td><td>(should_treat_LTBI == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>(HIV == 1) || (alcohol_abuse == 1) || (liver_disease_history == 1) || (chronic_hepatitis == 1) || (pregnant == 1) || (postpartum == 1) || (IVDA == 1) || [(age > 35) && (tolerates_INH == 1)]</td><td>&nbsp;</td></tr>
		<tr><td>73</td><td>baseline_indications_list</td><td>(should_treat_LTBI == 1) && (baseline_indications == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>list((HIV == 1)?desc(HIV):"", (alcohol_abuse == 1)?desc(alcohol_abuse):"", (liver_disease_history == 1)?desc(liver_disease_history):"", (chronic_hepatitis == 1)?desc(chronic_hepatitis):"", (pregnant == 1)?desc(pregnant):"", (postpartum == 1)?desc(postpartum):"", (IVDA == 1)?desc(IVDA):"", [(age > 35) && (tolerates_INH == 1)]?"is older than 35 years (if taking INH)":"")</td><td>&nbsp;</td></tr>
		<tr><td>74</td><td>need_baseline_CBC_LFT</td><td>(should_treat_LTBI == 1) && (baseline_indications == 1)</td><td>For your patient, `baseline_indications_list`, a baseline complete blood count and liver function tests should be done.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>75</td><td>monthly_indications</td><td>(should_treat_LTBI == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>((HIV == 1) || (alcohol_abuse == 1) || (liver_disease_history == 1) || (chronic_hepatitis == 1) || (pregnant == 1) || (postpartum == 1) || (IVDA == 1))</td><td>&nbsp;</td></tr>
		<tr><td>76</td><td>monthly_indications_list</td><td>(should_treat_LTBI == 1) &&  (monthly_indications == 1)</td><td><font color='blue'>[CALCULATED VALUE:]</font></br>list((HIV == 1)?desc(HIV):"", (alcohol_abuse == 1)?desc(alcohol_abuse):"", (liver_disease_history == 1)?desc(liver_disease_history):"", (chronic_hepatitis == 1)?desc(chronic_hepatitis):"", (pregnant == 1)?desc(pregnant):"", (postpartum == 1)?desc(postpartum):"", (IVDA == 1)?desc(IVDA):"")</td><td>&nbsp;</td></tr>
		<tr><td>77</td><td>need_monthly_LFT</td><td>(should_treat_LTBI == 1) &&  (monthly_indications == 1)</td><td>For your patient, `monthly_indications_list`, monthly liver function tests should be done.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
		<tr><td>78</td><td>conclusion</td><td>1</td><td>Apply this guideline again if clinical conditions change.</td><td><font color='blue'><b>[Data type = </b>instructions]</font></td></tr>
	</TABLE>
</BODY>
</HTML>
